Bank of New York Mellon
ETON icon

Bank of New York Mellon’s Eton Pharmaceutcials ETON Stock Holding History

Bank of New York Mellon’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Buy
118,249
+6,994
+6% +$205K ﹤0.01% 2533
2026
Q1 		$2.75M Sell
111,255
-16,445
-13% -$288K ﹤0.01% 2653
2025
Q4 		$2.16M Sell
127,700
-1,482
-1% -$26.1K ﹤0.01% 2788
2025
Q3 		$2.81M Buy
129,182
+1,838
+1% +$30.5K ﹤0.01% 2635
2025
Q2 		$1.81M Buy
127,344
+53,098
+72% +$839K ﹤0.01% 2798
2025
Q1 		$964K Hold
74,246
– – ﹤0.01% 3095
2024
Q4 		$989K Sell
74,246
-245
-0.3% -$2.48K ﹤0.01% 3172
2024
Q3 		$447K Hold
74,491
– – ﹤0.01% 3583
2024
Q2 		$245K Hold
74,491
– – ﹤0.01% 3893
2024
Q1 		$279K Sell
74,491
-4,911
-6% -$21.4K ﹤0.01% 3805
2023
Q4 		$348K Hold
79,402
– – ﹤0.01% 3737
2023
Q3 		$331K Hold
79,402
– – ﹤0.01% 3762
2023
Q2 		$277K Hold
79,402
– – ﹤0.01% 3869
2023
Q1 		$306K Buy
79,402
+530
+0.7% +$1.93K ﹤0.01% 3733
2022
Q4 		$222K Hold
78,872
– – ﹤0.01% 3927
2022
Q3 		$165K Hold
78,872
– – ﹤0.01% 4087
2022
Q2 		$207K Sell
78,872
-583
-0.7% -$1.96K ﹤0.01% 4043
2022
Q1 		$346K Hold
79,455
– – ﹤0.01% 3931
2021
Q4 		$341K Sell
79,455
-270
-0.3% -$1.29K ﹤0.01% 4030
2021
Q3 		$401K Buy
79,725
+66,450
+501% +$346K ﹤0.01% 3925
2021
Q2 		$82K Sell
13,275
-32,112
-71% -$238K ﹤0.01% 4251
2021
Q1 		$332K Sell
45,387
-260
-0.6% -$2.22K ﹤0.01% 3864
2020
Q4 		$371K Buy
45,647
+11,778
+35% +$90.9K ﹤0.01% 3748
2020
Q3 		$268K Buy
33,869
+315
+0.9% +$2.15K ﹤0.01% 3758
2020
Q2 		$182K Buy
+33,554
New +$167K ﹤0.01% 3812

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon's ETON Position: Q2 2026 in Review

Bank of New York Mellon increased its Eton Pharmaceutcials (ETON) stake by 6.3% in Q2 2026, buying an estimated $205K and bringing the position to 118,249 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Bank of New York Mellon first reported a position in ETON in Q2 2020 and has held it in 25 quarters since. 83 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Bank of New York Mellon held 118,249 shares of Eton Pharmaceutcials worth $4.28M as of Q2 2026.
  • Bank of New York Mellon bought 6,994 Eton Pharmaceutcials shares in Q2 2026, an estimated $205K.
  • Eton Pharmaceutcials made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2533 holding.
  • Bank of New York Mellon first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 25 quarters since.
  • 83 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.